LOGO
LOGO

Regency Centers Prices Offering Of 8 Mln Common Shares At $30.75 Per Share - Quick Facts

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Regency Centers Corp. (REG) announced that it has priced an offering of 8 million shares of its common stock at a price per share of $30.75, all of which will be subject to the forward sale agreements. Regency has also granted the underwriters a 30-day option to purchase up to an additional 1.20 million shares of its common stock to cover any over-allotments, which shares will not be subject to a forward sale agreement.

In connection with this offering, Regency has entered into forward sale agreements with affiliates of J.P. Morgan and Wells Fargo Securities, as forward purchasers.

Subject to customary conditions, the offering is expected to close on or about December 9, 2009.

Regency said that it intends to use any proceeds it receives upon settlement of the forward sale agreements, which are expected to be $235.8 million net of underwriters' discount and expenses, to repay or refinance maturing 2010 debt, which includes its pro rata share of the existing debt of a Regency co-investment partnership, Macquarie CountryWide-Regency II, as such partnership debt matures, and for general corporate purposes. This offering will allow Regency to use existing liquidity to prepay all or a portion of its existing term loan.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19